138 related articles for article (PubMed ID: 873570)
21. Reduced complement-mediated immune complex solubilizing capacity and the presence of incompletely solubilized immune complexes in SLE sera.
Baatrup G; Petersen I; Jensenius JC; Svehag SE
Clin Exp Immunol; 1983 Nov; 54(2):439-47. PubMed ID: 6652967
[TBL] [Abstract][Full Text] [Related]
22. Phagocytosis and degradation of DNA-anti-DNA complexes by human phagocytes: influence of the antibody class.
Lamers MC; de Groot ER; Roos D
Lab Invest; 1982 Apr; 46(4):393-9. PubMed ID: 7070053
[TBL] [Abstract][Full Text] [Related]
23. [Clinical application of Fc-rosette. III. Reduction of Fc receptor bearing cells in the peripheral blood of SLE and rheumatoid synovial fluids (author's transl)].
Nakai H; Morito T; Tanimoto K; Horiuchi Y
Ryumachi; 1977 Jul; 17(4):373-80. PubMed ID: 905902
[No Abstract] [Full Text] [Related]
24. Specific and shared idiotypes found on hybridoma anti-DNA autoantibodies derived from rheumatoid arthritis and systemic lupus erythematosus patients.
Rauch J; Massicotte H; Tannenbaum H
J Immunol; 1985 Oct; 135(4):2385-92. PubMed ID: 3875652
[TBL] [Abstract][Full Text] [Related]
25. Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis.
Elson CJ; Carter SD; Cottrell BJ; Scott DG; Bacon PA; Wallington TB
Clin Exp Immunol; 1985 Feb; 59(2):285-92. PubMed ID: 3978872
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of polymorphonuclear leukocyte chemiluminescence for detection of immune complexes in human sera.
Doll NJ; Wilson MR; Salvaggio JE
J Clin Invest; 1980 Sep; 66(3):457-64. PubMed ID: 6156953
[TBL] [Abstract][Full Text] [Related]
27. Evidence for intrinsic cellular defects of 'complement' receptor-mediated phagocytosis in patients with systemic lupus erythematosus (SLE).
Hurst NP; Nuki G; Wallington T
Clin Exp Immunol; 1984 Feb; 55(2):303-12. PubMed ID: 6697566
[TBL] [Abstract][Full Text] [Related]
28. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
[TBL] [Abstract][Full Text] [Related]
29. Impaired monocyte motility in sera from patients with systemic lupus erythematosus.
Sturfelt G; Linder C; Sjöholm AG; Svensson B
Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):151-8. PubMed ID: 6880748
[TBL] [Abstract][Full Text] [Related]
30. Binding of complement component C5 to model immune complexes and the use of anti-C5 antibodies for determination of C5-containing circulating immune complexes.
Larsson A; Sjöquist J
J Clin Lab Immunol; 1989 Jan; 28(1):5-9. PubMed ID: 2724329
[TBL] [Abstract][Full Text] [Related]
31. [Serum and articular immune complexes detection by the antibody-dependent cytotoxicity inhibition reaction in inflammatory rheumatological conditions and connective tissue disorders (author's transl)].
Meyer O; Descamps B; Ryckewaert A; Peltier A
Nouv Presse Med; 1979 Mar; 8(14):1165-9. PubMed ID: 313556
[TBL] [Abstract][Full Text] [Related]
32. Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease.
Skriner K; Sommergruber WH; Tremmel V; Fischer I; Barta A; Smolen JS; Steiner G
J Clin Invest; 1997 Jul; 100(1):127-35. PubMed ID: 9202064
[TBL] [Abstract][Full Text] [Related]
33. Monocyte cytotoxicity in connective tissue diseases. Correlation with disease groups.
Thorsteinsson L; Abrahamsen TG; Frøland SS; Kåss OE
Scand J Rheumatol; 1981; 10(1):49-54. PubMed ID: 6971489
[TBL] [Abstract][Full Text] [Related]
34. Ultrastructure of cells binding immunoglobulin-coated erythrocytes in rheumatoid arthritis.
Reyes F; Le Go A; Delrieu F; Bach JF
Clin Exp Immunol; 1974 Aug; 17(4):533-46. PubMed ID: 4468863
[TBL] [Abstract][Full Text] [Related]
35. Signals of monocyte activation in patients with SLE.
Kávai M; Zsindely A; Sonkoly I; Major M; Demján I; Szegedi G
Clin Exp Immunol; 1983 Feb; 51(2):255-60. PubMed ID: 6839541
[TBL] [Abstract][Full Text] [Related]
36. Anti-thyroglobulin anti-idiotypic antibodies in sera of patients with Hashimoto's thyroiditis and Graves' disease.
Sikorska HM
J Immunol; 1986 Dec; 137(12):3786-95. PubMed ID: 3782795
[TBL] [Abstract][Full Text] [Related]
37. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Russo K; Hoch S; Dima C; Varga J; Teodorescu M
J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
[TBL] [Abstract][Full Text] [Related]
38. Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes.
Nielsen CH; Rasmussen JM; Voss A; Junker P; Leslie RG
Arthritis Rheum; 1998 Apr; 41(4):613-22. PubMed ID: 9550470
[TBL] [Abstract][Full Text] [Related]
39. Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases.
Rosenbaum J; Pottinger BE; Woo P; Black CM; Loizou S; Byron MA; Pearson JD
Clin Exp Immunol; 1988 Jun; 72(3):450-6. PubMed ID: 3168322
[TBL] [Abstract][Full Text] [Related]
40. Monocyte in vitro function in systemic lupus erythematosus (SLE). II. Glass adherence and spreading in presence of SLE-sera.
Svensson B; Sturfelt G
Scand J Rheumatol Suppl; 1980; 31():43-52. PubMed ID: 6992267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
